Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythroid Precursor Cells | 13 | 2026 | 25 | 5.850 |
Why?
|
| Erythropoiesis | 20 | 2026 | 39 | 5.690 |
Why?
|
| Erythropoietin | 13 | 2026 | 38 | 2.930 |
Why?
|
| Cell Cycle | 8 | 2026 | 398 | 2.310 |
Why?
|
| Erythrocytes | 4 | 2021 | 146 | 1.460 |
Why?
|
| Erythroid Cells | 2 | 2025 | 13 | 1.420 |
Why?
|
| Receptors, Erythropoietin | 9 | 2021 | 10 | 1.310 |
Why?
|
| S Phase | 6 | 2024 | 79 | 1.280 |
Why?
|
| Erythroblasts | 9 | 2021 | 15 | 1.280 |
Why?
|
| Stress, Physiological | 6 | 2013 | 210 | 1.280 |
Why?
|
| Signal Transduction | 17 | 2024 | 3154 | 1.070 |
Why?
|
| Hematopoietic Stem Cells | 8 | 2020 | 299 | 1.070 |
Why?
|
| Cell Differentiation | 15 | 2026 | 1386 | 1.050 |
Why?
|
| Colony-Forming Units Assay | 2 | 2025 | 26 | 0.990 |
Why?
|
| Mice | 33 | 2026 | 11131 | 0.920 |
Why?
|
| Hypoxia | 1 | 2026 | 120 | 0.880 |
Why?
|
| fas Receptor | 3 | 2011 | 56 | 0.830 |
Why?
|
| Homeostasis | 3 | 2013 | 379 | 0.810 |
Why?
|
| Animals | 41 | 2026 | 21373 | 0.810 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 3 | 2022 | 7 | 0.790 |
Why?
|
| Flow Cytometry | 7 | 2022 | 663 | 0.790 |
Why?
|
| Stem Cells | 2 | 2022 | 276 | 0.790 |
Why?
|
| Cell Size | 1 | 2021 | 41 | 0.700 |
Why?
|
| Receptors, Transferrin | 4 | 2021 | 33 | 0.700 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2011 | 344 | 0.630 |
Why?
|
| Antigens, CD | 4 | 2021 | 342 | 0.630 |
Why?
|
| bcl-X Protein | 4 | 2021 | 24 | 0.610 |
Why?
|
| Embryonic Stem Cells | 1 | 2020 | 154 | 0.600 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 795 | 0.600 |
Why?
|
| DNA Replication | 3 | 2017 | 247 | 0.590 |
Why?
|
| Fas Ligand Protein | 3 | 2011 | 40 | 0.590 |
Why?
|
| Trans-Activators | 4 | 2010 | 321 | 0.570 |
Why?
|
| STAT5 Transcription Factor | 5 | 2012 | 14 | 0.560 |
Why?
|
| Fetus | 4 | 2021 | 102 | 0.530 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 195 | 0.510 |
Why?
|
| Hematopoiesis | 5 | 2020 | 127 | 0.480 |
Why?
|
| Cell Survival | 5 | 2021 | 586 | 0.450 |
Why?
|
| Models, Biological | 3 | 2021 | 1192 | 0.440 |
Why?
|
| Interleukin-17 | 2 | 2025 | 99 | 0.430 |
Why?
|
| Liver | 6 | 2021 | 871 | 0.400 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2013 | 6 | 0.390 |
Why?
|
| Polycythemia Vera | 1 | 2013 | 7 | 0.390 |
Why?
|
| beta-Thalassemia | 1 | 2013 | 15 | 0.390 |
Why?
|
| DNA Methylation | 2 | 2011 | 305 | 0.370 |
Why?
|
| Milk Proteins | 3 | 2001 | 45 | 0.350 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 152 | 0.330 |
Why?
|
| Embryo, Mammalian | 3 | 2021 | 158 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 11 | 2025 | 3488 | 0.330 |
Why?
|
| Mice, Inbred BALB C | 7 | 2018 | 868 | 0.330 |
Why?
|
| Receptors, Prolactin | 3 | 2002 | 6 | 0.320 |
Why?
|
| Receptors, Cytokine | 3 | 1998 | 13 | 0.310 |
Why?
|
| Apoptosis | 6 | 2011 | 1098 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2018 | 32 | 0.280 |
Why?
|
| Macrophages | 1 | 2013 | 1038 | 0.260 |
Why?
|
| Anemia | 3 | 2012 | 132 | 0.260 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2020 | 663 | 0.260 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2025 | 500 | 0.260 |
Why?
|
| Mice, Transgenic | 3 | 2026 | 1290 | 0.240 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2020 | 119 | 0.240 |
Why?
|
| Membrane Proteins | 1 | 2011 | 924 | 0.230 |
Why?
|
| Aging | 1 | 2011 | 773 | 0.220 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2025 | 48 | 0.210 |
Why?
|
| DNA-Binding Proteins | 3 | 2001 | 1225 | 0.210 |
Why?
|
| Genome | 2 | 2020 | 285 | 0.210 |
Why?
|
| Transcription, Genetic | 4 | 2017 | 907 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2001 | 104 | 0.190 |
Why?
|
| Integrin alpha6 | 1 | 2022 | 20 | 0.190 |
Why?
|
| Female | 11 | 2021 | 34095 | 0.190 |
Why?
|
| Reticulocytes | 1 | 2021 | 12 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2021 | 32 | 0.180 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 72 | 0.180 |
Why?
|
| CD4 Antigens | 1 | 2021 | 149 | 0.170 |
Why?
|
| Cell Division | 3 | 2020 | 450 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 181 | 0.170 |
Why?
|
| Feedback, Physiological | 2 | 2014 | 59 | 0.170 |
Why?
|
| Iron | 1 | 2021 | 155 | 0.160 |
Why?
|
| Oxygen | 2 | 2014 | 319 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 687 | 0.160 |
Why?
|
| Single-Cell Analysis | 2 | 2018 | 117 | 0.160 |
Why?
|
| Hematologic Diseases | 1 | 2020 | 12 | 0.160 |
Why?
|
| Endodeoxyribonucleases | 1 | 2019 | 45 | 0.150 |
Why?
|
| Humans | 14 | 2025 | 65268 | 0.150 |
Why?
|
| Mast Cells | 2 | 2018 | 51 | 0.150 |
Why?
|
| Male | 8 | 2021 | 31123 | 0.150 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1631 | 0.150 |
Why?
|
| Cells, Cultured | 5 | 2020 | 2188 | 0.150 |
Why?
|
| Th1 Cells | 1 | 2019 | 171 | 0.150 |
Why?
|
| Basophils | 1 | 2018 | 15 | 0.140 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2018 | 6 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2021 | 631 | 0.140 |
Why?
|
| Cell Lineage | 2 | 2018 | 282 | 0.140 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 301 | 0.130 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 239 | 0.130 |
Why?
|
| Interferon-gamma | 1 | 2019 | 574 | 0.130 |
Why?
|
| Mice, Knockout | 5 | 2016 | 2158 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2010 | 324 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 156 | 0.130 |
Why?
|
| Cytokines | 2 | 1998 | 951 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2016 | 4 | 0.120 |
Why?
|
| Osteoclasts | 1 | 2016 | 53 | 0.120 |
Why?
|
| Spleen | 2 | 2011 | 476 | 0.120 |
Why?
|
| Bone Resorption | 1 | 2016 | 46 | 0.120 |
Why?
|
| Prospective Studies | 1 | 2022 | 3312 | 0.110 |
Why?
|
| Osteoblasts | 1 | 2016 | 204 | 0.110 |
Why?
|
| Pinocytosis | 1 | 1994 | 4 | 0.110 |
Why?
|
| Transcriptome | 1 | 2018 | 399 | 0.110 |
Why?
|
| Receptors, IgG | 1 | 1994 | 41 | 0.100 |
Why?
|
| Systems Biology | 1 | 2014 | 36 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2003 | 422 | 0.100 |
Why?
|
| ras Proteins | 2 | 2003 | 76 | 0.100 |
Why?
|
| Phagocytosis | 1 | 1994 | 257 | 0.090 |
Why?
|
| Inflammation | 1 | 2019 | 1192 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2012 | 8 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 14 | 0.090 |
Why?
|
| Immunoglobulin G | 1 | 1994 | 466 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2012 | 241 | 0.090 |
Why?
|
| Locus Control Region | 1 | 2011 | 4 | 0.090 |
Why?
|
| beta-Globins | 1 | 2011 | 10 | 0.090 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2011 | 20 | 0.090 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2011 | 18 | 0.090 |
Why?
|
| Dinucleoside Phosphates | 1 | 2011 | 32 | 0.090 |
Why?
|
| Atmosphere | 1 | 2011 | 3 | 0.090 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 42 | 0.090 |
Why?
|
| Receptors, Fc | 1 | 2011 | 25 | 0.090 |
Why?
|
| Chromatin | 2 | 2020 | 642 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2012 | 377 | 0.090 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2011 | 40 | 0.080 |
Why?
|
| Hematocrit | 2 | 2001 | 32 | 0.080 |
Why?
|
| CpG Islands | 1 | 2011 | 219 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2011 | 142 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2301 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 414 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2012 | 962 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 277 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 345 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2011 | 351 | 0.070 |
Why?
|
| Algorithms | 2 | 2018 | 1050 | 0.070 |
Why?
|
| Cell Separation | 1 | 2007 | 147 | 0.060 |
Why?
|
| Mitochondria | 1 | 2011 | 410 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2006 | 1575 | 0.060 |
Why?
|
| Leukemia | 1 | 2007 | 62 | 0.060 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2006 | 10 | 0.060 |
Why?
|
| Cell Line | 3 | 2001 | 2024 | 0.050 |
Why?
|
| Half-Life | 1 | 2025 | 81 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 542 | 0.050 |
Why?
|
| Adult | 1 | 2021 | 17398 | 0.050 |
Why?
|
| Protein Engineering | 1 | 2025 | 85 | 0.050 |
Why?
|
| Pregnancy | 1 | 2011 | 2375 | 0.050 |
Why?
|
| Genes, ras | 1 | 2003 | 28 | 0.050 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 45 | 0.050 |
Why?
|
| Genotype | 2 | 2003 | 673 | 0.050 |
Why?
|
| Mammary Glands, Animal | 1 | 2002 | 76 | 0.040 |
Why?
|
| Erythrocyte Count | 1 | 2001 | 15 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2001 | 22 | 0.040 |
Why?
|
| Vascular Neoplasms | 1 | 2001 | 18 | 0.040 |
Why?
|
| Ligases | 1 | 2001 | 27 | 0.040 |
Why?
|
| Hemangioma | 1 | 2001 | 27 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 78 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 513 | 0.040 |
Why?
|
| Chromosomes, Mammalian | 1 | 2020 | 33 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2020 | 28 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 1999 | 8 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1999 | 30 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 210 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2001 | 226 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 1999 | 68 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 1998 | 27 | 0.040 |
Why?
|
| Prolactin | 1 | 1998 | 40 | 0.040 |
Why?
|
| Drug Synergism | 1 | 1998 | 142 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2001 | 308 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 46 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2019 | 197 | 0.030 |
Why?
|
| Rabbits | 1 | 1998 | 338 | 0.030 |
Why?
|
| Tyrosine | 1 | 1998 | 93 | 0.030 |
Why?
|
| Base Sequence | 1 | 1999 | 1332 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1999 | 586 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 710 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 1589 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2001 | 1979 | 0.030 |
Why?
|
| Bone Density | 1 | 2016 | 142 | 0.030 |
Why?
|
| Proteins | 1 | 2001 | 764 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2016 | 176 | 0.030 |
Why?
|
| Rosette Formation | 1 | 1994 | 12 | 0.030 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1994 | 8 | 0.030 |
Why?
|
| Zymosan | 1 | 1994 | 24 | 0.030 |
Why?
|
| Sheep | 1 | 1994 | 193 | 0.030 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2011 | 9 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 122 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 1224 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2011 | 63 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 292 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 3769 | 0.020 |
Why?
|
| Cytosol | 1 | 2011 | 182 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 541 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 426 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 433 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2005 | 19 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 80 | 0.010 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2005 | 22 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2005 | 84 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 129 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 237 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2005 | 213 | 0.010 |
Why?
|
| MyoD Protein | 1 | 2003 | 45 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 197 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 401 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2003 | 200 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 896 | 0.010 |
Why?
|
| Heart | 1 | 2003 | 298 | 0.010 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2001 | 9 | 0.010 |
Why?
|
| Polycythemia | 1 | 2001 | 5 | 0.010 |
Why?
|
| Albumins | 1 | 2001 | 43 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 233 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 173 | 0.010 |
Why?
|
| Biopolymers | 1 | 2001 | 72 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 921 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 413 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 415 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 426 | 0.010 |
Why?
|
| Retroviridae | 1 | 1999 | 75 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 1999 | 56 | 0.010 |
Why?
|
| Alleles | 1 | 2001 | 453 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2001 | 506 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1998 | 22 | 0.010 |
Why?
|
| Lung | 1 | 2003 | 966 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1998 | 23 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 787 | 0.010 |
Why?
|
| DNA Repair | 1 | 1999 | 262 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 251 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 325 | 0.010 |
Why?
|
| Phenotype | 1 | 2001 | 1233 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 2666 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1999 | 921 | 0.010 |
Why?
|
| DNA | 1 | 1998 | 858 | 0.010 |
Why?
|